1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. News
  7. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
Delayed Xetra  -  05/27 11:35:06 am EDT
69.35 EUR   +2.59%
05/26GERRESHEIMER AG : JP Morgan remains Neutral
MD
05/25GERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
05/16Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities in India
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gerresheimer : Ueli Utzinger appointed new Group Senior Director Communication & Marketing at Gerresheimer

12/01/2021 | 04:11am EDT
Ueli Utzinger, Group Senior Director Communication & Marketing, Gerresheimer AG

Duesseldorf, December 1, 2021 - Ueli Utzinger is to become Gerresheimer AG's new Group Senior Director Communication & Marketing as of December 1, 2021. He succeeds Jens Kürten, who is pursuing new opportunities after 12 years of successful marketing and communication work for the company.

Gerresheimer's strategic goal is to transform itself into a growth company that is positioned as a dynamic innovation leader and solution provider and acts like one - something reflected in the company's new visual presence and new corporate slogan "Innovating for a better life." Both were developed and rolled out in spring 2021 by a team led by the external marketing and communication consultant Ueli Utzinger. This successful relationship is now set to continue on a permanent basis, with Utzinger taking over as Gerresheimer AG's Group Senior Director Communication & Marketing as of December 1, 2021.

For the past 30 years, Utzinger has developed and successfully implemented marketing and communication concepts for international industrial and pharmaceutical companies, as well as financial service providers. In this context, he was also responsible for brand strategy, development and management for these companies.

Dietmar Siemssen, Chief Executive Officer of Gerresheimer, is delighted to have Utzinger on board: "Ueli Utzinger has supported our strategy process every step of the way and actively shaped its development. He has shown himself to be a dynamic high performer and a source of valuable input. He will ensure that our customers, partners, investors, stakeholders and employees can see and experience our transformation process through active and creative communication activities."

Utzinger replaces Jens Kürten, who is leaving Gerresheimer to pursue new career opportunities after 12 years of successful marketing and communication work. Siemssen has these words for the departing head of marketing and communication: "Jens Kürten has done an outstanding job in the past 12 years. Thanks to his professional work, he has played a key role in making Gerresheimer one of today's globally leading providers of pharma, biotech and beauty solutions and products. The Management Board of Gerresheimer would like to warmly thank him for his achievements and wishes him all the best for the future, both professionally and personally."

To ensure a smooth transition, Kürten will remain at the company to support his successor until February 18, 2022.

About Gerresheimer

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.

Disclaimer

Gerresheimer AG published this content on 01 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2021 09:10:07 UTC.


© Publicnow 2021
All news about GERRESHEIMER AG
05/26GERRESHEIMER AG : JP Morgan remains Neutral
MD
05/25GERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
05/16Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities..
CI
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boostin..
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
05/09Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients w..
CI
05/09GERRESHEIMER AG : Gerresheimer and Portal enter strategic partnership to treat chronically..
EQ
04/13GERRESHEIMER AG : Credit Suisse reiterates its Buy rating
MD
04/12GERRESHEIMER AG : JP Morgan gives a Neutral rating
MD
04/11GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank
MD
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
Financials
Sales 2022 1 687 M 1 807 M 1 807 M
Net income 2022 117 M 125 M 125 M
Net Debt 2022 1 050 M 1 125 M 1 125 M
P/E ratio 2022 18,8x
Yield 2022 1,92%
Capitalization 2 178 M 2 333 M 2 333 M
EV / Sales 2022 1,91x
EV / Sales 2023 1,77x
Nbr of Employees 10 625
Free-Float 100%
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 69,35 €
Average target price 92,11 €
Spread / Average Target 32,8%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-18.12%2 333
ABBOTT LABORATORIES-17.09%204 317
MEDTRONIC PLC-4.22%131 850
BECTON, DICKINSON AND COMPANY2.74%73 108
HOYA CORPORATION-19.93%39 352
BAXTER INTERNATIONAL INC.-11.28%38 349